About
Overview
Leadership Team
Board of Directors
Advisors
Partnership Opportunities
Contact Us
Science
Overview
Presentations & Publications
Pipeline
Overview
RNS60
RNS60 for Ischemic Stroke
RNS60 for ALS
Discovery Programs
Patient Access
News
Press Releases
Careers
Culture
Open Positions
Connect with us
info@revalesio.com
FROM PRESS
to presentations
News
July 31, 2025
Revalesio Receives FDA Fast Track Designation for RNS60 for the Treatment of Acute Ischemic Stroke
July 21, 2025
Revalesio Announces Publication of RESCUE Phase 2 Trial Results Evaluating RNS60 as an Adjunctive Therapy for Acute Ischemic Stroke in the Journal Stroke
July 14, 2025
Revalesio to Present Phase 3 Trial Design and Post Hoc Analysis of Phase 2 RESCUE trial of RNS60 in Acute Ischemic Stroke at the SNIS 22nd Annual Meeting
All news